Preventing clinical heart failure: the rationale and scientific evidence.
作者信息
Wood D A
机构信息
Cardiovascular Medicine, Charing Cross Hospital, Cardiology Department, 5th Floor, Fulham Palace Road, London W6 8RF, UK.
出版信息
Heart. 2002 Oct;88 Suppl 2(Suppl 2):ii15-22. doi: 10.1136/heart.88.suppl_2.ii15.
Abstract
摘要
相似文献
1
Preventing clinical heart failure: the rationale and scientific evidence.
Heart. 2002 Oct;88 Suppl 2(Suppl 2):ii15-22. doi: 10.1136/heart.88.suppl_2.ii15.
2
Incidence and aetiology of heart failure; a population-based study.
Eur Heart J. 1999 Mar;20(6):421-8. doi: 10.1053/euhj.1998.1280.
3
The epidemiology of heart failure secondary to coronary artery disease.
Coron Artery Dis. 1998;9(10):625-8.
4
Epidemiologic aspects of heart failure.
Am Heart J. 1990 Dec;120(6 Pt 2):1538-40. doi: 10.1016/0002-8703(90)90055-3.
5
The natural history of congestive heart failure: the Framingham study.
N Engl J Med. 1971 Dec 23;285(26):1441-6. doi: 10.1056/NEJM197112232852601.
6
Lifestyle and dietary modification for prevention of heart failure.
Med Clin North Am. 2004 Sep;88(5):1295-320, xii. doi: 10.1016/j.mcna.2004.02.003.
7
[A pilot survey of the main causes of chronic heart failure in patients treated in primary hospitals in China].
Zhonghua Nei Ke Za Zhi. 2005 Jul;44(7):487-9.
8
Letter by Marcadenti and Oliveira de Abreu Silva regarding article, "Chocolate intake and incidence of heart failure: a population-based, prospective study of middle-aged and elderly women".
Circ Heart Fail. 2011 Jan;4(1):e5; author reply e6. doi: 10.1161/CIRCHEARTFAILURE.110.959403.
9
Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?
Expert Rev Cardiovasc Ther. 2009 Feb;7(2):147-57. doi: 10.1586/14779072.7.2.147.
10
Epidemiological aspects of heart failure.
Cardiol Clin. 1989 Feb;7(1):1-9.
引用本文的文献
1
Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling.
Sci Rep. 2018 Apr 19;8(1):6277. doi: 10.1038/s41598-018-24749-6.
2
Mesenchymal stromal cells: current understanding and clinical status.
Stem Cells. 2010 Mar 31;28(3):585-96. doi: 10.1002/stem.269.
3
Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro.
Exp Mol Med. 2009 Jul 31;41(7):508-16. doi: 10.3858/emm.2009.41.7.056.
4
G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
J Exp Med. 2006 Jan 23;203(1):87-97. doi: 10.1084/jem.20051151. Epub 2006 Jan 9.
5
Therapies to prevent heart failure post-myocardial infarction.
Curr Heart Fail Rep. 2005 Dec;2(4):174-82. doi: 10.1007/BF02696647.
本文引用的文献
1
Coronary artery disease as the cause of incident heart failure in the population.
Eur Heart J. 2001 Feb;22(3):228-36. doi: 10.1053/euhj.2000.2289.
2
Survival of patients with a new diagnosis of heart failure: a population based study.
Heart. 2000 May;83(5):505-10. doi: 10.1136/heart.83.5.505.
3
The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94.
Diabet Med. 1999 Jan;16(1):35-40. doi: 10.1046/j.1464-5491.1999.00017.x.
4
Incidence and aetiology of heart failure; a population-based study.
Eur Heart J. 1999 Mar;20(6):421-8. doi: 10.1053/euhj.1998.1280.
5
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction.
J Am Coll Cardiol. 1999 Mar 15;33(4):916-23. doi: 10.1016/s0735-1097(98)00675-5.
6
Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.
Circulation. 1998 Nov 24;98(21):2282-9. doi: 10.1161/01.cir.98.21.2282.
7
Blood pressure screening, management and control in England: results from the health survey for England 1994.
J Hypertens. 1998 Jun;16(6):747-52. doi: 10.1097/00004872-199816060-00005.
8
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.
J Card Fail. 1997 Dec;3(4):249-54. doi: 10.1016/s1071-9164(97)90022-1.
9
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
J Am Coll Cardiol. 1997 Feb;29(2):229-36. doi: 10.1016/s0735-1097(96)00489-5.
10
Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.
J Am Coll Cardiol. 1996 Apr;27(5):1214-8. doi: 10.1016/0735-1097(95)00606-0.
Zotero 插件